SCHEMBL3312403

SCHEMBL3312403

COc1ccc(-c2ccc(C(=O)C=C(O)C(=O)O)s2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
ALDH1A1 P00352 2/20 0.58
MAPT P10636 2/20 0.58
HPGD P15428 2/20 0.58
NPC1 O15118 1/20 0.58
GLA P06280 1/20 0.58
GAA P10253 1/20 0.58
LMNA P02545 1/20 0.56
APP P05067 5/20 0.51
HSD17B2 P37059 7/20 0.51
HSD17B1 P14061 4/20 0.49
HDAC6 Q9UBN7 1/20 0.44
ACKR3 P25106 1/20 0.43
PTPN1 P18031 1/20 0.43
TP53 P04637 1/20 0.43
CASP1 P29466 1/20 0.43
CASP7 P55210 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3312397 1.00 KDM4E (0.58) KDM4ESMN1; SMN2ALDH1A1MAPTHPGD
SCHEMBL3312400 1.00 KDM4E (0.58) KDM4ESMN1; SMN2ALDH1A1MAPTHPGD
SCHEMBL3308374 0.89 KDM4E (0.59) KDM4ESMN1; SMN2ALDH1A1MAPTHPGD
SCHEMBL3308378 0.89 KDM4E (0.59) KDM4ESMN1; SMN2ALDH1A1MAPTHPGD
SCHEMBL3314440 0.85 RAB9A (0.48) KDM4ESMN1; SMN2ALDH1A1MAPTHPGD
SCHEMBL3314437 0.85 RAB9A (0.48) KDM4ESMN1; SMN2ALDH1A1MAPTHPGD
SCHEMBL3314445 0.85 RAB9A (0.48) KDM4ESMN1; SMN2ALDH1A1MAPTHPGD
SCHEMBL3309252 0.82 ESRRG (0.51) APPHSD17B2HSD17B1
SCHEMBL3309246 0.82 ESRRG (0.51) APPHSD17B2HSD17B1
SCHEMBL3309254 0.82 ESRRG (0.51) APPHSD17B2HSD17B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-06-19 US claimed
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-06-19 US disclosed
US-8664255-B2 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof THE TEXAS A&M UNIVERSITY SYSTEM (US) 2014-03-04 US disclosed
US-20100113477-A1 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof TEXAS A&M UNIVERSITY SYSTEM, THE 2010-05-06 US disclosed
WO-2010047774-A2 INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS MALATE SYNTHASE, METHODS OF MARKING AND USES THEREOF THE TEXAS A & M UNIVERSITY SYSTEM (US) 2010-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113477-A1 Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof ME3, ME1, MDH1 KDM4E 1397/4885SMN1; SMN2 4781/4885ALDH1A1 620/4885
US-20140171444-A1 Inhibitors of Mycobacterium Tuberculosis Malate Synthase, Methods of Making and Uses Thereof ME3, ME1, MDH1 KDM4E 1397/4885SMN1; SMN2 4781/4885ALDH1A1 620/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.